Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV
· Real-Time Price · USD
1.82
0.04 (2.25%)
At close: Aug 15, 2025, 3:59 PM
1.96
7.69%
After-hours: Aug 15, 2025, 06:42 PM EDT
2.25% (1D)
Bid | 1.9 |
Market Cap | 43.41M |
Revenue (ttm) | n/a |
Net Income (ttm) | -14.33M |
EPS (ttm) | -0.66 |
PE Ratio (ttm) | -2.76 |
Forward PE | -2.42 |
Analyst | Strong Buy |
Ask | 2 |
Volume | 2,191,622 |
Avg. Volume (20D) | 203,111 |
Open | 1.92 |
Previous Close | 1.78 |
Day's Range | 1.76 - 2.10 |
52-Week Range | 0.81 - 2.10 |
Beta | 0.80 |
About ENLV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENLV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENLV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
+20.37%
Elivex Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
8 months ago
-5.24%
Enlivex Therapeutics shares are trading higher after the company announced its board approved the purchase of up to $1 million in Bitcoin.